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Bulimia: Medical Complications
PHILIP S. MEHLER, M.D.,1,2 CYNTHIA CREWS, M.D.,1,2 and KENNETH WEINER, M.D.3,4
ABSTRACT
Bulimia nervosa is a common eating disorder that predominantly affects young women. There
are three main models of purging in bulimia. Resulting medical complications are related to
the particular mode and frequency of purging. Commonly, there are oral and gastrointestinal
complications along with serious electrolyte and endocrine complications. The majority of
the medical complications of bulimia nervosa are treatable if diagnosed in a timely fashion.
Some of these patients require inpatient hospitalization, and others can be managed along a
continuum of outpatient care. The American Psychiatric Association has comprehensive treat-
ment guidelines for the management of bulimia. Primary care physicians and gynecologists
need to be familiar with this disorder and its medical implications.
INTRODUCTION
BULIMIA NERVOSA WAS FIRST IDENTIFIED as a dis-tinct disorder by Gerald Russell, M.D., in the
late 1970s.1 As with anorexia nervosa, bulimia
nervosa is an illness that afflicts primarily young
females ages 12–35, although recently there has
been an increased incidence in women in midlife.
The reported lifetime prevalence of anorexia ner-
vosa in females ranges form 0.5% to 3.7%.2,3 In
comparison, bulimia nervosa has a lifetime
prevalence of 1%–4% and may be as high as 19%
in certain select groups of female college stu-
dents.4–6 These numbers may be misleading,
however, because many more persons are af-
flicted with eating disorders that fall short of the
formal diagnostic criteria for bulimia nervosa or
anorexia nervosa but are no less debilitating.
Binge eating (similar to bulimia nervosa except it
lacks the purging component), for example, has
been reported in close to 80% of female college
undergraduates. The ratio of female/male pa-
tients is in the range of 10:1–20:1.
DIAGNOSTIC CRITERIA
Although there are a few physical and labora-
tory findings that are strongly suggestive of bu-
limia nervosa, the diagnosis is based on specific
behavioral criteria (Table 1). A high index of sus-
picion in the right clinical setting, together with
sensitivity and respect for the patient, will aid the
clinician in eliciting the historical features neces-
sary for making the diagnosis. The high preva-
lence of this disorder in young women would
seem to mandate routine screening in this popu-
lation, although this has not yet been established
1Department of Internal Medicine, Denver Health, Denver, Colorado.
2Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado.
3Eating Disorders Center of Denver, Colorado.
4Department of Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado.
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as the standard of care. There are, however, a few
recently developed screening questionnaires that
seem to have reasonable utility to diagnose bu-
limia.7 According to the American Psychiatric As-
sociation’s Diagnostic and Statistical Manual of
Mental Disorders, 4th edition (DSM-IV), bulimia
nervosa is characterized by recurrent episodes of
binge eating and purging or other compensatory
weight loss behaviors occurring at least twice a
week for 3 months, an undue influence of body
shape and weight on self-image, and the occur-
rence of these behaviors at times other than dur-
ing episodes of anorexia nervosa.8
There are two subtypes of bulimia nervosa,
purging and nonpurging. The purging type is
characterized by self-induced vomiting or the use
of laxatives or diuretics to induce weight loss and
counteract the sequelae of binge eating. The non-
purging type, in contrast, is characterized by fast-
ing or engaging in excessive exercise and the
compensatory behaviors for avoiding weight
gain from binge eating episodes. To meet clinical
criteria according to DSM-IV, binges and the re-
sulting compensatory behavior must occur at a
minimum of two times a week for a period of 3
months. Variants that do not clearly fall into ei-
ther category include the use of diet pills or thy-
roid hormone, chewing and spitting out food,
and in the case of patients with diabetes mellitus,
skipping insulin doses to induce an osmotic di-
uresis and weight loss.
Bulimia nervosa frequently shares company
with other psychiatric disorders, including sub-
stance abuse, depression, bipolar disorder, anxi-
ety disorders, and posttraumatic stress disorder
(PTSD) (up to 37%).9–12 In fact, their inherent
compulsiveness predisposes these patients to
other addictive psychosocial behaviors, such as
stealing, drug abuse, and alcohol dependence.13
When present, these comorbid conditions need to
be diagnosed and treated effectively to maximize
treatment outcomes in individuals suffering from
an eating disorder. The complexity of these pa-
tients is best served by a multidisciplinary treat-
ment team.14
Weight preoccupation is a primary symptom in
both anorexia nervosa and bulimia nervosa, and
many patients demonstrate a mixture of both
anorexic and bulimic symptoms. Up to 50% of 
patients with anorexia nervosa develop bulimic
symptoms, and some patients who are initially bu-
limic develop anorexic symptoms.15 The risk of
death in bulimia is substantially lower than that in
anorexia nervosa, but it is still higher than in age-
matched females in the population as a whole.16
The pathogenesis of bulimia nervosa can be
best understood using a biopsychosocial model.
Genetic studies have identified a clear biological
basis for eating disorders, and, in fact, anorexia
nervosa is as inheritable as schizophrenia. If a wo-
man’s mother or sister has anorexia nervosa, her
lifetime incidence is 12 times greater than the
norm for developing anorexia nervosa and 4
times greater than the norm for developing bu-
limia nervosa. However, it is clear that although
genetics may load the gun, life—that is, family,
trauma, dieting, social pressures, western me-
dia/advertising—pulls the trigger. Many pa-
tients have been exposed to teasing about their
body shape, and often these patients have the
trait of excessive perfectionism and the negative
self-evaluation with which it is associated.17
MEDICAL COMPLICATIONS
There are three main modes of purging: self-
induced vomiting, abuse of laxatives, and misuse
of diuretics. Most patients with bulimia induce
vomiting with their finger, but some use ipecac.
As the illness progresses, many can simply turn
their heads and vomit reflexively without me-
chanical stimulation. The laxatives abused are the
stimulant type containing bisacodyl, cascara, or
senna. Diuretic preparations and diet pills, such
as those containing ephedrine, are used less fre-
quently. The medical complications of bulimia
nervosa are related to the mode and frequency of
purging, whereas in anorexia nervosa, they arise
as a result of starvation (restricting) and weight
loss (Table 2).
TABLE 1. DSM-IV CRITERIA FOR BULIMIA NERVOSAa
Binge eating (2 times/week for 3 months)
Purging or other compensatory weight loss measures 
(2 times/week for 3 months)
Regular self-induced vomiting or misuse of laxatives or
diuretics in the purging type; other inappropriate 
compensatory behavior, such as fasting or excessive
exercise, in the nonpurging type
Self-image unduly influenced by body weight or shape
Absence of anorexia nervosa
aAmerican Psychiatric Association. Diagnostic and 
Statistical Manual of Mental Disorders, 4th ed. Washington,
DC: APA, 1994.
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In a study involving 275 women with bulimia
nervosa, the most common symptoms were
weakness (83.6%), feeling bloated (75.2%), puffy
cheeks (50.1%), dental problems (36.5%), and fin-
ger calluses (27.4%).18
Renal and electrolyte abnormalities
A number of electrolyte and acid-base abnor-
malities may result from bulimia nervosa, de-
pending on whether the method of purging used
is self-induced vomiting, diuretic misuse, or lax-
ative abuse. Hypokalemia is the most serious ab-
normality, as it may cause cardiac arrhythmias,
rhabdomyolysis, muscle weakness, hypokalemic
cardiomyopathy, and tetany. The prevalence of
hypokalemia is low and occurs in 4.6% of bulimic
patients; it is primarily found in lower-weight bu-
limics who vomit or use laxatives or both.19 Given
its low sensitivity, screening for hypokalemia
cannot be recommended as a means of detecting
bulimia nervosa because its absence does not ex-
clude the diagnosis. On the other hand, finding
hypokalemia in an otherwise healthy young wo-
man is very specific for bulimia nervosa and sug-
gests daily vomiting or diuretic abuse.
Several mechanisms contribute to the devel-
opment of hypokalemia in bulimia nervosa. There
is a direct loss of potassium as a result of vomit-
ing. The concomitant loss of chloride ions and gas-
tric acid leads to a hypokalemic-hypochloremic
metabolic alkalosis. Laxative abuse causes loss of
potassium and bicarbonate in the stool, resulting
in hypokalemia and a nonanion gap metabolic aci-
dosis. Some diuretics cause renal wasting of
potassium. The more significant cause of hy-
pokalemia is activated when purging of any type
results in a significant degree of volume deple-
tion. Then, the renal renin-angiotensin hormonal
system is activated, leading to high ambient lev-
els of these hormones. These, in turn, drive the re-
nal retention of sodium in exchange for loss of hy-
drogen and potassium ions, which are excreted in
the urine. This results in a metabolic alkalosis in
bulimic patients who purge excessively through
either self-induced vomiting or diuretic abuse.
The most severe cases of metabolic alkalosis are
seen with self-induced vomiting (Table 3).
The normotensive, hypokalemic, hypochlor-
emic metabolic alkalosis seen in many patients
with bulimia is known as pseudo-Bartter’s syn-
drome and has significant therapeutic implica-
tions. Specifically, the efficacy of potassium re-
pletion is abrogated unless there is concomitant
normalization of the hypovolemic state.20,21 On
occasion, a bulimic patient will seek care in an
emergency room and be found to have severe 
hypokalemia. Despite massive amounts of po-
tassium repletion, such patients remain hypo-
kalemic because their fluid status has not been
MEHLER ET AL.670
TABLE 2. MEDICAL COMPLICATIONS OF BULIMIA
Renal Cardiovascular
Hypokalemia Hypotension
Hyperchloremic metabolic acidosis Syncope
Hyperamylasemia Arrhythmias
Nonanion gap metabolic acidosis Cardiomyopathy
Pseudo-Bartter’s syndrome Mitral valve prolapse
Idiopathic edema
Oral Endocrine
Perimolysis Irregular menses
Sialadenosis False positive dexamethasone
Xerostomia suppression test
Oral mucosal erythema Hypoglycemia
Cheilitis Diabetes mellitus
Gastrointestinal
Esophagitis
Dyspepsia
Gastroesophageal reflux disease
Esophageal rupture
Melanosis coli
Atonic colon
Cathartic colon
Steatorrhea
Protein-losing gastroenteropathy
Gastrointestinal bleeding
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normalized as well. Correcting the volume status
improves the metabolic alkalosis and inactivates
the renin-angiotensin axis, allowing successful
potassium repletion.
A good rule of thumb is that every decrease of
1 mmol/L in the serum potassium level repre-
sents a loss of 100–150 mmol in total body potas-
sium. For repletion, oral potassium chloride is
generally preferred. Typically, potassium is ad-
ministered in a split dose of 40–80 mEq/day for
a few days, with subsequent measurements of the
potassium level to ensure normalization.
Another manifestation of pseudo-Bartter’s syn-
drome is the development of lower extremity
edema in those who purge excessively via vom-
iting, laxatives, or diuretics and then abruptly
stop. The unopposed high levels of aldosterone,
caused by the abrupt cessation of purging, can
cause marked salt retention and edema. Attempts
to self-treat this condition with diuretics will ex-
acerbate the problem. Salt restriction, lower ex-
tremity elevation, and patience are usually all
that is necessary to resolve this problem. Occa-
sionally, it is prudent to prescribe a short, 2-week
course of a potassium-sparing diuretic, such as
spironolactone, to negate the effects of aldo-
sterone and treat the edema, particularly when
the distress over edema threatens a relapse in the
patient’s bulimic behaviors.
Oral complications
The most obvious oral health disorder seen in
bulimia is tooth enamel erosion (perimyolysis).
This erosion occurs primarily on the lingual and
occlusal surfaces of the maxillary dentition but
may also be seen on the facial surfaces in later
stages of disease. The erosion is caused by re-
gurgitation of acidic gastric contents on a repeti-
tive basis during self-induced vomiting. The low
pH of gastric contents is below the critical thresh-
old for enamel mineralization.22 Enamel erosion
is usually seen after 6 months of self-induced
vomiting and is ubiquitous in those who have
had the disorder for 5 years.23 Erosion may
cause thermal tooth hypersensitivity from dentin
exposure. Unfortunately, once tooth enamel is
eroded, it will not regenerate, and restorative
dental procedures may be necessary. It remains
controversial whether the mechanical abrasion
from toothbrushing immediately after vomiting
worsens this erosion, and several experts recom-
mend mouthwashing with neutralizing solu-
tions, such as sodium bicarbonate.22
Despite commonly bingeing with foods high in
carbohydrate and fat content, patients with bu-
limia have lower rates of dental caries, plaque,
and periodontal disease. This may be the result
of compulsive oral hygiene practices in this pop-
ulation.24
Parotid gland enlargement (sialadenosis) is a
particularly bothersome disorder seen in patients
with bulimia. Enlargement occurs not immedi-
ately but after a patient has been in the binge-
purge cycle for some time. Once enlargement oc-
curs, however, it can reappear quickly when
vomiting resumes. The prevalence of parotid en-
largement is estimated to be between 10% and
50% in bulimic patients and occasionally involves
swelling of the submandibular glands. Clinically,
the swelling develops 3–6 days after a binge-
purge episode has stopped, and its severity is
thought to be related to the frequency of vomit-
ing behavior. The swelling is usually painless but
can be quite disfiguring and, therefore, emotion-
ally disturbing to a patient who is already self-
conscious about her physical appearance.
TABLE 3. ELECTROLYTE VALUES USUALLY ASSOCIATED WITH PURGING
Serum
Sodium Potassium Chloride Bicarbonate
Purging (138–147 (3.7–5.2 (101–112 (22–28 pH
method mmol/L) mmol/L) mmol/L) mmol/L) (7.38–7.42) Sodium Potassium Chloride
Vomiting Increased, Decreased Decreased Increased Increased Decreased Increased Decreased
decreased,
normal
Laxative use Increased, Decreased Increased, Decreased, Decreased Decreased Decreased Normal
normal normal normal
Diuretic use Decreased, Decreased Decreased Increased Increased Increased Increased Increased
normal
Urine
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Histologically, parotid gland enlargement is
noninflammatory, but the glands exhibit an in-
crease in acinar size and in the number of secre-
tory granules. The mechanism of this enlarge-
ment is not entirely clear, but theories include:
1. Work hypertrophy, where repeated chewing
and intake of carbohydrate-rich food hyper-
stimulate glands
2. Autonomic stimulation of salivary glands by
pancreatic proteolytic enzymes brought into
the mouth during emesis, which stimulate lin-
gual taste receptors
3. Cholinergic stimulation of salivary glands by
vomitus, increasing saliva production and se-
cretion, which causes acinar hypertrophy
Treatment of parotid gland enlargement begins
with cessation of self-induced vomiting, heat ap-
plications, and the use of sialagogues, such as tart
candy. For patients unresponsive to these mea-
sures, pilocarpine hydrochloride tablets (5 mg
three times per day) may be useful.25 In unre-
sponsive cases, parotidectomy is an option but
may cause worsened cosmetic deformity and is
rarely indicated.
Erythema of the oral mucosa occurs as a con-
sequence of chronic irritation from vomited gas-
tric contents. Frequently, patients will complain
of pharyngeal, palatal, and gingival soreness.
Cheilosis is characterized by pallor, maceration,
and in severe cases, painful fissures involving the
angles of the mouth. Vitamin B12 deficiency
should be excluded, and efforts should be made
toward correction of the primary oral abnormal-
ity to maintain lip hygiene and prevent leakage
of saliva through the corners of the mouth.
Gastrointestinal effects
The two main sites in the gastrointestinal tract
affected by bulimia are the esophagus and colon.
Esophageal involvement is found in patients who
purge through self-induced vomiting. Depending
on the frequency of vomiting, which can range
from once to more than 10 times a day, the result
may be esophagitis, esophageal ulcers, strictures,
or rupture.
Although rare, esophageal rupture (Boer-
haave’s syndrome) in bulimia is life threatening;
the overall mortality is approximately 20%. Early
surgical intervention, however, is generally cura-
tive. The presentation includes severe chest pain,
mediastinitis, and pleural effusions; if the diag-
nosis is delayed, tachycardia and hypotension
may develop.
Barrett’s esophagus, in which columnar ep-
ithelium replaces normal squamous epithelium
as a result of chronic irritation from recurrent re-
flux or vomiting of acidic stomach contents, has
also been described in bulimia. Esophageal ade-
nocarcinoma develops in approximately 0.5% of
patients with Barrett’s esophagus per year.26
Esophageal complications give rise to frequent
complaints of sore throat, dyspepsia, dysphagia,
or hematemesis.27 The last is usually the result of
Mallory-Weiss tears or esophagitis. Spontaneous
reflux of gastric contents into the lower esopha-
gus can also occur and causes significant heart-
burn as a result of laxity of the lower esophageal
sphincter after months of repeated vomiting.
Treatment for esophageal complications of bu-
limia is similar to that for gastroesophageal re-
flux disease. Acid suppression with a proton
pump inhibitor is of value in this regard. In the
patient who tends to vomit spontaneously, a pro-
kinetic agent, such as metoclopramide, is worth
considering. It acts by increasing lower esoph-
ageal sphincter tone and hastening gastric emp-
tying and, hence, can be a useful adjunct in se-
verely affected patients.
Patients with bulimia nervosa who purge
through laxatives may also experience complaints
referable to the colon.28 Some patients may ingest
up to 50 laxative pills per day to achieve their de-
sired result. A review of 73 studies of laxative
abuse revealed a lifetime incidence of 27.2%
among patients with bulimia nervosa compared
with 4.18% in the general population. Chronic
abuse of stimulant cathartics (compounds con-
taining senna or cascara) can cause melanosis coli
(a reversible brown-black discoloration of the
colonic mucosa and submucosa), a benign finding.
In addition, these patients can develop an atonic
colon, resulting in chronic constipation and laxa-
tive dependence, or a cathartic colon, a perma-
nently flaccid and dilated colon that cannot prop-
agate fecal material, resulting from damage to the
neurological innervation of the intestine. Cathar-
tic colon may cause refractory constipation re-
quiring bowel resection.29 A previously abused
stimulant laxative, phenolphthalein, was removed
from the market a few years ago because of con-
cern about its association with colon cancer.
Constipation is particularly problematic dur-
ing attempts to withdraw stimulant laxatives in
MEHLER ET AL.672
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a bulimic patient.30 Laxative withdrawal is best
managed by anticipatory counseling, including
setting the expectation that constipation and pos-
sibly rebound edema may occur but typically re-
solve within 10 days to 3 weeks. Patients should
also be advised that regular exercise, adequate
fluid intake, the addition of such bulk-forming
agents as fiber or psyllium to the diet, and in some
cases, an osmotic laxative, such as lactulose, will
be necessary. Stool softeners are of little clinical
value.31
Patients’ misconceptions about stimulant laxa-
tives should be addressed. Moreover, they should
be told that laxatives are an ineffective means of
weight loss because their site of action is the large
intestine, where they cause temporary fluid loss
without concomitant caloric losses. Relapse to
stimulant laxative abuse will worsen the depen-
dency on them and increase the risk of more re-
fractory constipation. Steatorrhea, protein-losing
gastroenteropathy, and gastrointestinal bleeding
have also been reported as a result of laxative
abuse.
Cardiovascular complications
Cardiovascular complications occasionally re-
sult from the purging behaviors used by bulim-
ics. Excessive purging of any type may cause vol-
ume depletion, which can cause dizziness,
hypotension, or even syncope. Purging may also
cause hypokalemia, which can lead to arrhyth-
mias. The repeated use of ipecac to induce vom-
iting can cause an irreversible and potentially fa-
tal cardiomyopathy. Ipecac is usually sold in
bottles containing 30 ml of syrup of ipecac, the
equivalent of 21 mg of emetine base, which is the
toxic component. An estimated total dose of 1.25
g of emetine base may be fatal,32 and lesser doses
may cause skeletal and cardiac muscle myopa-
thy. The drug is excreted slowly, so accumulation
over time is a major concern. Mitral valve pro-
lapse may be more prevalent among bulimic wo-
men and usually resolves with weight gain. On
occasion, these patients may complain of palpi-
tations or even chest pain as a result thereof and,
similarly, if ephedrine-type diet supplements are
abused.
Endocrine effects
There appears to be an increased prevalence of
bulimia in patients with insulin-dependent dia-
betes.33 Such patients may deliberately omit or re-
duce their insulin injections to induce diuresis
and weight loss. In this regard, some of the be-
haviors that are important in dietary manage-
ment of diabetes may set the stage for an eating
disorder. Specifically, traditional dietary regi-
mens that limit sweets teach patients to avoid cer-
tain foods and may thus promote abnormal eat-
ing habits. Although the causal relationship
between bulimia and diabetes is debated, the
detrimental effects of this combination are clear.
In diabetic patients with bulimia, end-organ dam-
age develops at a younger age than in age-
matched nonbulimic diabetic patients.34 Glyco-
sylated hemoglobin values are elevated in many
diabetic patients with bulimia because of the
metabolic effects of binge eating, noncompliance
with dietary regimens, and deliberate omission of
insulin in order to produce an osmotic diuresis
and weight loss.
In contrast to anorexia nervosa, other en-
docrine manifestations are not prominent in bu-
limia.35 Compared with the general population,
persons with bulimia nervosa appear to have a
higher prevalence of nonsuppression on the dex-
amethasone suppression test, ranging between
20% and 67% in different studies.18 This lack of
suppression remains unexplained. Oligomenor-
rhea may occur in bulimia nervosa during
episodes of active bulimia, but amenorrhea is in-
frequent.14 This is in marked contrast to anorexia
nervosa, where amenorrhea is a universal find-
ing. The future ability of bulimic patients to con-
ceive does not appear to be impaired.36 Of note,
although many women with bulimia will have re-
duced symptomatology during pregnancy, this is
often followed by an exacerbation of symptoms
after delivery.37
Similarly, in contrast to anorexia, wherein the
prevalence of osteoporosis is very high,38 bone
density is generally normal in bulimic patients
unless there has been a prior history of anorexia
nervosa and marked weight loss. In this instance,
bone densitometry would be warranted. Russell’s
sign, that is, erosions covering the dorsum of the
hands, is a result of using one’s finger to self-in-
duce vomiting.39
SITE OF TREATMENT
Most medical complications of bulimia can be
treated in the outpatient setting by a primary care
doctor or provider with expertise in dealing with
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these patients. Primary care providers should use
a multidisciplinary approach when managing
these patients, especially the more severe cases.
The team should include a psychologist/psychi-
atrist and a nutritionist. Patients with severe bu-
limia nervosa may benefit from a referral to a cen-
ter specializing in eating disorders. The main role
of the primary care provider is to screen for and
diagnose the disorder and then manage any med-
ical complications that arise while the patient is
engaged in therapy.
Factors that suggest a need for hospitalization
include severe depression, marked dehydration
and disabling symptoms, purging that is rapidly
worsening and has proved refractory to out-
patient treatment, severe hypokalemia (plasma
potassium level 2.0–3.0 mmol/L), and major or-
thostatic changes in blood pressure (30 mm Hg)
and pulse (30 beats per minute). Data are lack-
ing on how these factors affect the ultimate out-
come.40
SUMMARY
Bulimia nervosa is an increasingly common
disorder among young women, especially in in-
dustrialized countries. Not only can it have ad-
verse physical effects, but it can also wreak havoc
on the emotional and social lives of these patients.
The physical signs of this disorder can be subtle
and easily overlooked unless specifically sought.
Likewise, normal laboratory abnormalities are
unreliable for excluding the disorder. The art 
of medicine comes into play in the evaluation 
and treatment of persons with bulimia nervosa.
Adopting an accepting rather than a judgmental
attitude will aid the clinician in establishing trust
with the patient, eliciting the historical details
necessary to make the diagnosis, and offering the
necessary medical treatment to negate the litany
of medical complications that can occur with bu-
limia.
REFERENCES
1. LaVia M, Kaye WH, Andersen A, et al. Anorexia ner-
vosa: Criteria for levels of care. Eating Disorders Re-
search Society Annual Meeting, Boston, 1998.
2. Garfinkel PE, Lin E, Goering P, et al. Should amen-
orrhea be necessary for the diagnosis of anorexia ner-
vosa? Br J Psychiatry 1996;168:500.
3. Walters EE, Kendler KS. Anorexia nervosa and
anorexic-like syndromes in a population based female
twin sample. Am J Psychiatry 1995;152:64.
4. Garfinkel PE, Lin E, Goering P, et al. Bulimia nervosa
in a Canadian community sample: Prevalence and
comparison of subgroups. Am J Psychiatry 1995;152:
1052.
5. Kendler KS, MacLean C, Neale M, Kessler R, Heath
A, Eaves L. The genetic epidemiology of bulimia ner-
vosa. Am J Psychiatry 1991;148:1627.
6. Pyle R, Mitchell J, Eckert E. The incidence of bulimia
in freshman college students. Int J Eat Disord 1988;
2:75.
7. Cotton MA, Ball C, Robinson P. Four simple ques-
tions to help screen for eating disorders. J Gen Intern
Med 2003;18:53.
8. American Psychiatric Association. Diagnostic and sta-
tistical manual of mental disorders, 4th ed. Washing-
ton, DC: American Psychiatric Association, 1994.
9. Holderness C, Brooks-Gunn J, Warren M. Comorbid-
ity of eating disorders and substance abuse: Review
of the literature. Int J Eat Disord 1994;16:1.
10. Cooper PJ. Eating disorders and their relationship to
mood and anxiety disorders. Brownell KD, Fairburn
CG, eds. In: Eating disorders and obesity: A com-
prehensive handbook. New York: Guilford Press,
1995:159.
11. Edelstein CK, Yager J. Eating disorders and affective
disorders. In: Yager J, Gwirtsman HE, Edelstein CK,
eds. Special problems in managing eating disor-
ders. Washington, DC: American Psychiatric Press,
1992:15.
12. Dansky BS, Brewerton TD, Kilpatrick DG, O’Neil PM.
The national women’s study: Relationship of victim-
ization and posttraumatic stress disorder to bulimia
nervosa. Int J Eat Disord 1997;21:213.
13. Bulik CM, Sullivan PF, Cater FA, Joyce PR. Lifetime
comorbidity of alcohol dependence in women with
bulimia nervosa. Addict Behav 1997;22:437.
14. Weiner KL. In: Eating disorders: A guide to medical
care and complications. Mehler PS, Andersen AE, eds.
Baltimore, MD: Johns Hopkins University Press, 1999,
pgs. 27–44.
15. Musisi S, Garfinkel P. Comparative dexamethasone
suppression test measurements in bulimia, depres-
sion and normal controls. Can J Psychiatry 1985;30:
190.
16. Keel PK, Mitchell JE. Outcome in bulimia nervosa.
Am J Psychiatry 1997;154:313.
17. Fairburn CG, Doll HA, Welch SL, Hay PS, Davis BA,
O’Connor ME. Risk factors for binge eating disorders.
Arch Gen Psychiatry 1998;55:425.
18. Mitchell JE, Hatsukami D, Eckert ED, Pyle RI. Char-
acteristics of 275 patients with bulimia. Am J Psychi-
atry 1985;142:482.
19. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Hy-
pokalemia in outpatients with eating disorders. Am J
Psychiatry 1995;152:60.
20. Mehler PS. Electrolyte disorders in bulimia. Eating
disorders. J Prev Treat 1998;6:65.
MEHLER ET AL.674
5135_e12_p668-675  7/27/04  1:36 PM  Page 674
MEDICAL COMPLICATIONS OF BULIMIA 675
21. Mehler PS. In: Eating disorders: A guide to medical
care and complications. Mehler PS, Andersen AE, 
eds. Baltimore, MD: Johns Hopkins University Press,
1999, pgs. 76–86.
22. Milosevic A, Brodie DA, Slade PD. Dental erosion,
oral hygiene, and nutrition in eating disorders. Int J
Eat Disord 1997;21:195.
23. Althshuler BD, Dechow PC, Waller DA, Hardy BW.
An investigation of the oral pathologies occurring in
bulimia nervosa. Int J Eat Disord 1990;9:191.
24. Milosevic A. Eating disorders and the dentist. Br Dent
J 1999;186:109.
25. Mehler PS, Wallace JA. Sialadenosis in bulimia. A new
treatment. Arch Otolaryngol Head Neck Surg 1993;
119:787.
26. Spechler SJ. Barrett’s esophagus. N Engl J Med 2002;
346:836.
27. Mendell DA, Logemann JA. Bulimia and swallowing:
Cause for concern. Int J Eat Disord 2001;30:252.
28. Mitchell JE, Hatsukami D, Eckert ED, Pyle RI. Char-
acteristics of 275 patients with bulimia. Am J Psychi-
atry 1985;142:482.
29. Camilleri M, Thompson G, Fleshman JW, Pemberton
JH. Clinical management of intractable constipations.
Ann Intern Med 1994;121:520.
30. Cotton P, Woodside DB, Kaplan AS. Laxative with-
drawal in eating disorders. Treatment protocol and 3
to 20 month follow-up. Int J Eat Disord 1999;25:311.
31. Tramonte SM, Brand MB, Mulrow CD, Amato MG,
O’Keefe ME, Ramirez G. The treatment of chronic
constipation in adults. J Gen Intern Med 1997;12:15.
32. Ho PC, Diveik R, Cohen MC. Reversible cardiomy-
opathy associated with chronic ipecac. Clin Cardiol
1998;21:780.
33. Takii M, Uchigata Y, Nozaki T, et al. Classification of
type 1 diabetic females with bulimia nervosa into sub-
groups according to purging behavior. Diabetes Care
2002;25:1571.
34. Rydall AC, Rodin GM, Olmsted MP, Devenyi RG,
Daneman D. Disordered eating behavior and mi-
crovascular complications in young women with in-
sulin-dependent diabetes mellitus. N Engl J Med
1997;336:1849.
35. Mehler PS. Diagnosis and care of patients with
anorexia nervosa in primary care settings. Ann Intern
Med 2001;134:1048.
36. Crow SJ, Thuras P, Keel PK, Mitchell JE. Long-term
menstrual and reproductive function in patients with
bulimia nervosa. Am J Psychiatry 2002;159:1048.
37. Conrad R, Schablewski J, Schilling G, Liedtke R.
Worsening of symptoms of bulimia nervosa during
pregnancy. Psychosomatics 2003;44:76.
38. Zipfel S, Seibel MJ, Lowee B, Beumont PJ, Kasperk C,
Herzog W. Osteoporosis in eating disorders: A fol-
low-up study of patients with anorexia and bulimia
nervosa. J Clin Endocrinol Metab 2001;86:5227.
39. Gloria R, Allevato M, De Pablo A, et al. Prevalence of
continuous manifestations in 200 patients with eating
disorders. Int J Dermetol 2000;39:348.
40. Woodside DB. Inpatient treatment and medical man-
agement of anorexia nervosa and bulimia nervosa. In:
Eating disorders and obesity: A comprehensive hand-
book, 2nd ed. Fairburn CG, Brownell KD, eds. New
York: Guilford Press, 2002:335.
Address reprint requests to:
Philip S. Mehler, M.D.
c/o Denver Health and Hospitals
660 Bannock Street, MC0278
Denver, CO 80204
E-mail: Pmehler@dhha.org
5135_e12_p668-675  7/27/04  1:36 PM  Page 675
